• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状旁腺激素可预测急性ST段抬高型心肌梗死直接经皮冠状动脉介入治疗后的院内主要不良心血管事件。

PTH Predicts the in-Hospital MACE After Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction.

作者信息

Wu Zu-Fei, Su Wen-Tao, Chen Shi, Xu Bai-Da, Zong Gang-Jun, Fang Cun-Ming, Huang Zheng, Hu Xue-Jun, Wu Gang-Yong, Ma Xiao-Lin

机构信息

Department of Cardiology, Xuancheng People's Hospital, Xuanchen, Anhui, 242000, People's Republic of China.

Department of Cardiology, the 904th Hospital of the PLA Joint Logistics Support Force, Wuxi, Jiangsu, 214044, People's Republic of China.

出版信息

Ther Clin Risk Manag. 2023 Aug 23;19:699-712. doi: 10.2147/TCRM.S420335. eCollection 2023.

DOI:10.2147/TCRM.S420335
PMID:37641783
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10460584/
Abstract

OBJECTIVE

To investigate the correlation between serum parathyroid hormone (PTH) levels and in-hospital major adverse cardiovascular events (MACE) in patients with acute ST-segment elevation myocardial infarction (STEMI) after primary percutaneous coronary intervention (PCI), and establish a risk prediction model based on parameters such as PTH for in-hospital MACE.

METHODS

This observational retrospective study consecutively enrolled 340 patients who underwent primary PCI for STEMI between January 2016 and December 2020, divided into a MACE group (n=92) and a control group (n=248). The least absolute shrinkage and selection operator (LASSO) and logistic regression analyses were used to determine the risk factors for MACE after primary PCI. The rms package in R-studio statistical software was used to construct a nomogram, to detect the line chart C-index, and to draw a calibration curve. The decision curve analysis (DCA) method was used to evaluate the clinical application value and net benefit.

RESULTS

Correlation analysis revealed that PTH level positively correlated with the occurrence of in-hospital MACE. Receiver operating characteristic curve analyses revealed that PTH had a good predictive value for in-hospital MACE. Multivariate logistic regression analysis indicated that Killip class II-IV, and FBG were independently associated with in-hospital MACE after primary PCI. A nomogram model was constructed using the above parameters. The model C-index was 0.894 and the calibration curve indicated that the model was well calibrated. The DCA curve suggested that the nomogram model was better than TIMI score model in terms of net clinical benefit.

CONCLUSION

Serum PTH levels in patients with STEMI are associated with in-hospital MACE after primary PCI, and the nomogram risk prediction model based on PTH demonstrated good predictive ability with obvious clinical practical value.

摘要

目的

探讨急性ST段抬高型心肌梗死(STEMI)患者在直接经皮冠状动脉介入治疗(PCI)后血清甲状旁腺激素(PTH)水平与院内主要不良心血管事件(MACE)之间的相关性,并基于PTH等参数建立院内MACE的风险预测模型。

方法

本观察性回顾性研究连续纳入了2016年1月至2020年12月期间因STEMI接受直接PCI的340例患者,分为MACE组(n = 92)和对照组(n = 248)。采用最小绝对收缩和选择算子(LASSO)及逻辑回归分析来确定直接PCI后MACE的危险因素。使用R-studio统计软件中的rms包构建列线图,检测线图C指数,并绘制校准曲线。采用决策曲线分析(DCA)方法评估临床应用价值和净效益。

结果

相关性分析显示PTH水平与院内MACE的发生呈正相关。受试者工作特征曲线分析显示PTH对院内MACE具有良好的预测价值。多因素逻辑回归分析表明,Killip分级II-IV级和空腹血糖(FBG)与直接PCI后的院内MACE独立相关。使用上述参数构建了列线图模型。该模型的C指数为0.894,校准曲线表明模型校准良好。DCA曲线表明,在净临床效益方面,列线图模型优于TIMI评分模型。

结论

STEMI患者的血清PTH水平与直接PCI后的院内MACE相关,基于PTH的列线图风险预测模型具有良好的预测能力,具有明显的临床实用价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33dd/10460584/6dd71fb17d1b/TCRM-19-699-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33dd/10460584/6921be566418/TCRM-19-699-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33dd/10460584/c10427fb36f1/TCRM-19-699-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33dd/10460584/6ba2f2c837be/TCRM-19-699-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33dd/10460584/d3efec869abe/TCRM-19-699-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33dd/10460584/1c51c6a43da8/TCRM-19-699-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33dd/10460584/2509ccdb25ce/TCRM-19-699-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33dd/10460584/6dd71fb17d1b/TCRM-19-699-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33dd/10460584/6921be566418/TCRM-19-699-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33dd/10460584/c10427fb36f1/TCRM-19-699-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33dd/10460584/6ba2f2c837be/TCRM-19-699-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33dd/10460584/d3efec869abe/TCRM-19-699-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33dd/10460584/1c51c6a43da8/TCRM-19-699-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33dd/10460584/2509ccdb25ce/TCRM-19-699-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33dd/10460584/6dd71fb17d1b/TCRM-19-699-g0007.jpg

相似文献

1
PTH Predicts the in-Hospital MACE After Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction.甲状旁腺激素可预测急性ST段抬高型心肌梗死直接经皮冠状动脉介入治疗后的院内主要不良心血管事件。
Ther Clin Risk Manag. 2023 Aug 23;19:699-712. doi: 10.2147/TCRM.S420335. eCollection 2023.
2
Construction and evaluation of nomogram model for individualized prediction of risk of major adverse cardiovascular events during hospitalization after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.急性ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后住院期间主要不良心血管事件风险个体化预测列线图模型的构建与评估
Front Cardiovasc Med. 2022 Dec 21;9:1050785. doi: 10.3389/fcvm.2022.1050785. eCollection 2022.
3
Predictive value of triglyceride glucose index combined with neutrophil-to-lymphocyte ratio for major adverse cardiac events after PCI for acute ST-segment elevation myocardial infarction.三酰甘油葡萄糖指数联合中性粒细胞与淋巴细胞比值对急性 ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗后主要不良心脏事件的预测价值。
Sci Rep. 2024 Jun 2;14(1):12634. doi: 10.1038/s41598-024-63604-9.
4
In-hospital major adverse cardiovascular events after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: a retrospective study under the China chest pain center (standard center) treatment system.急性 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后的院内主要心血管不良事件:中国胸痛中心(标准版)治疗体系下的回顾性研究。
BMC Cardiovasc Disord. 2023 Apr 17;23(1):198. doi: 10.1186/s12872-023-03214-x.
5
A nomogram risk prediction model for no-reflow after primary percutaneous coronary intervention based on rapidly accessible patient data among patients with ST-segment elevation myocardial infarction and its relationship with prognosis.基于ST段抬高型心肌梗死患者快速获取的患者数据的直接经皮冠状动脉介入术后无复流的列线图风险预测模型及其与预后的关系。
Front Cardiovasc Med. 2022 Aug 8;9:966299. doi: 10.3389/fcvm.2022.966299. eCollection 2022.
6
Establishment and validation of a risk model for prediction of in-hospital mortality in patients with acute ST-elevation myocardial infarction after primary PCI.建立并验证一个预测直接经皮冠状动脉介入治疗(PCI)后急性 ST 段抬高型心肌梗死患者院内死亡率的风险模型。
BMC Cardiovasc Disord. 2020 Dec 9;20(1):513. doi: 10.1186/s12872-020-01804-7.
7
Predictive values of bilirubin for in-hospital adverse events in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.经皮冠状动脉介入治疗后 ST 段抬高型心肌梗死患者胆红素对住院不良事件的预测价值。
Clinics (Sao Paulo). 2023 Nov 8;78:100306. doi: 10.1016/j.clinsp.2023.100306. eCollection 2023.
8
Establishment and validation of nomogram model for predicting major adverse cardiac events in patients with acute ST-segment elevation myocardial infarction based on glycosylated hemoglobin A1c to apolipoprotein A1 ratio: An observational study.基于糖化血红蛋白 A1c 与载脂蛋白 A1 比值的急性 ST 段抬高型心肌梗死患者主要不良心脏事件预测的列线图模型的建立与验证:一项观察性研究。
Medicine (Baltimore). 2024 Jun 14;103(24):e38563. doi: 10.1097/MD.0000000000038563.
9
Establishment and validation of a nomogram model containing a triglyceride-glucose index and neutrophil-to-high-density lipoprotein ratio for predicting major adverse cardiac events in patients with ST-segment elevation myocardial infarction.建立并验证了一个包含三酰甘油-葡萄糖指数和中性粒细胞与高密度脂蛋白比值的列线图模型,用于预测 ST 段抬高型心肌梗死患者的主要不良心脏事件。
J Int Med Res. 2024 Sep;52(9):3000605241258181. doi: 10.1177/03000605241258181.
10
Establishment and validation of a clinical nomogram model based on serum YKL-40 to predict major adverse cardiovascular events during hospitalization in patients with acute ST-segment elevation myocardial infarction.基于血清YKL-40建立并验证临床列线图模型以预测急性ST段抬高型心肌梗死患者住院期间主要不良心血管事件
Front Med (Lausanne). 2023 May 22;10:1158005. doi: 10.3389/fmed.2023.1158005. eCollection 2023.

引用本文的文献

1
Association between adjusted atherogenic index of plasma and major adverse cardiovascular events after percutaneous coronary intervention in patients with STEMI: a prospective observational study in China.ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后血浆校正致动脉粥样硬化指数与主要不良心血管事件的关联:一项中国的前瞻性观察研究
BMJ Open. 2025 Aug 21;15(8):e096065. doi: 10.1136/bmjopen-2024-096065.
2
Risk factors for major cardiovascular adverse events and the effects of sacubitril/valsartan in patients with acute myocardial infarction after Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后急性心肌梗死患者发生主要心血管不良事件的危险因素及沙库巴曲缬沙坦的作用
Pak J Med Sci. 2025 Jun;41(6):1592-1597. doi: 10.12669/pjms.41.6.10819.
3

本文引用的文献

1
Cardiogenic Shock After Acute Myocardial Infarction: A Review.急性心肌梗死后心原性休克:综述。
JAMA. 2021 Nov 9;326(18):1840-1850. doi: 10.1001/jama.2021.18323.
2
Changes in the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios before and after percutaneous coronary intervention and their impact on the prognosis of patients with acute coronary syndrome.经皮冠状动脉介入治疗前后中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值的变化及其对急性冠状动脉综合征患者预后的影响。
Clinics (Sao Paulo). 2021 Aug 4;76:e2580. doi: 10.6061/clinics/2021/e2580. eCollection 2021.
3
Parathormone levels add prognostic ability to N-terminal pro-brain natriuretic peptide in stable coronary patients.
Development and validation of a nomogram model for predicting lymph node metastasis in early non-small-cell lung cancer.
早期非小细胞肺癌淋巴结转移预测列线图模型的构建与验证
Am J Cancer Res. 2025 Jan 15;15(1):299-310. doi: 10.62347/JBKV3746. eCollection 2025.
4
Evaluation of the age-specific relationship between PTH and vitamin D metabolites.甲状旁腺激素(PTH)与维生素D代谢产物之间年龄特异性关系的评估。
Bone Rep. 2024 Aug 26;22:101800. doi: 10.1016/j.bonr.2024.101800. eCollection 2024 Sep.
甲状旁腺激素水平为稳定型冠心病患者的 N 端脑利钠肽前体提供预后能力。
ESC Heart Fail. 2021 Aug;8(4):2713-2722. doi: 10.1002/ehf2.13331. Epub 2021 May 1.
4
Percutaneous coronary intervention during on- and off-hours in patients with ST-segment elevation myocardial infarction.经皮冠状动脉介入治疗在 ST 段抬高型心肌梗死患者的工作时间和非工作时间。
Hellenic J Cardiol. 2021 May-Jun;62(3):212-218. doi: 10.1016/j.hjc.2021.01.011. Epub 2021 Feb 1.
5
Establishment and validation of a risk model for prediction of in-hospital mortality in patients with acute ST-elevation myocardial infarction after primary PCI.建立并验证一个预测直接经皮冠状动脉介入治疗(PCI)后急性 ST 段抬高型心肌梗死患者院内死亡率的风险模型。
BMC Cardiovasc Disord. 2020 Dec 9;20(1):513. doi: 10.1186/s12872-020-01804-7.
6
A radiomic nomogram for prediction of major adverse cardiac events in ST-segment elevation myocardial infarction.用于预测 ST 段抬高型心肌梗死患者主要不良心脏事件的放射组学列线图。
Eur Radiol. 2021 Feb;31(2):1140-1150. doi: 10.1007/s00330-020-07176-y. Epub 2020 Aug 27.
7
Longitudinal Changes in Kidney Function Estimated from Cystatin C and Its Association with Mortality in Elderly Women.胱抑素 C 估算的肾功能纵向变化及其与老年女性死亡率的关系。
Nephron. 2020;144(6):290-298. doi: 10.1159/000507256. Epub 2020 May 11.
8
Association between the mortality rate and operator volume in patients undergoing emergency or elective percutaneous coronary interventions.患者行急诊或择期经皮冠状动脉介入治疗的死亡率与术者手术量的关系。
Kardiol Pol. 2020 Feb 25;78(2):138-146. doi: 10.33963/KP.15123. Epub 2020 Jan 5.
9
Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study.基线血浆纤维蛋白原与急性冠状动脉综合征患者经皮冠状动脉介入治疗后血红蛋白 A1c 和 2 年主要不良心血管事件相关:一项单中心前瞻性队列研究。
Cardiovasc Diabetol. 2019 Apr 23;18(1):52. doi: 10.1186/s12933-019-0858-5.
10
Hypertension and chronic kidney disease affect long-term outcomes in patients with stable coronary artery disease receiving percutaneous coronary intervention.高血压和慢性肾脏病会影响接受经皮冠状动脉介入治疗的稳定型冠状动脉疾病患者的长期预后。
Sci Rep. 2018 Dec 5;8(1):17673. doi: 10.1038/s41598-018-35982-4.